Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Hippocampal Temporal Interference Stimulation for Memory and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

8 novembre 2026 mis à jour par: Jiaojiao Lü, PhD, Shanghai University of Sport

Effects and Underlying Mechanisms of Hippocampal-Targeted Temporal Interference Stimulation on Memory Function and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

This randomized crossover study aims to investigate the immediate effects of hippocampal temporal interference stimulation (TIS) on memory and dual-task postural control in older adults with mild cognitive impairment (MCI).

Participants are assigned to receive three stimulation conditions: 40 Hz TIS, 5 Hz TIS, and sham stimulation. Each condition is administered in a separate session in a randomized order, with at least 7 days between consecutive sessions.

The study compares memory and dual-task postural control across the three stimulation conditions. Memory and dual-task postural control assessments are planned before and after each stimulation session.

Aperçu de l'étude

Statut

Recrutement

Type d'étude

Interventionnel

Inscription (Estimé)

21

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: Jiaojiao Lü, PhD
  • Numéro de téléphone: +86 18516565889
  • E-mail: ljj27@163.com

Lieux d'étude

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Chine, 200438
        • Recrutement
        • Shanghai University of Sport
        • Contact:
          • Ethics Committee of the Shanghai University of Sport
          • Numéro de téléphone: +86 21 65508179
          • E-mail: lunli@sus.edu.cn

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

65 ans et plus (Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

  1. Age 65 years or older.
  2. Presence of subjective memory complaints.
  3. Objective cognitive impairment, defined as a corrected MoCA-BJ total score of less than 26. The MoCA-BJ has a maximum score of 30. For participants with no more than 12 years of education, 1 point is added to the raw score, and the corrected total score is capped at 30 points.
  4. Global Clinical Dementia Rating (CDR) score of 0.5.
  5. No diagnosis of dementia, with an MMSE score of at least 18 for illiterate participants, at least 21 for those with primary school education, and at least 25 for those with junior high school education or above.
  6. Remains independent in activities of daily living (ADL) and is able to cooperate with all assessments and interventions.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation croisée
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: 40 Hz Temporal Interference Stimulation

Participants receive one 20-minute session of active 40 Hz temporal interference stimulation (TIS) targeting the left hippocampus. In this randomized crossover study, participants are also assigned to receive 5 Hz TIS and sham stimulation in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the 40 Hz stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Autres noms:
  • TIs
Comparateur factice: sham group

Participants receive one 20-minute session of sham temporal interference stimulation (TIS), using the same electrode placement and setup as the 40 Hz TIS session. In this randomized crossover study, participants are also assigned to receive 40 Hz and 5 Hz TIS in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the sham stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Autres noms:
  • TIs
Expérimental: 5 Hz Temporal Interference Stimulation

Participants receive one session of active 5 Hz temporal interference stimulation (TIS). In this randomized crossover study, participants are also assigned to receive 40 Hz TIS and sham stimulation in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the 5 Hz stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Autres noms:
  • TIs

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change From Pre-intervention in Object-Scene Associative Memory Retrieval Accuracy After Stimulation
Délai: Immediately before and after each 20-minute stimulation session during each crossover period

Accuracy is assessed using a computerized object-scene associative memory task programmed in E-Prime 3.0. Accuracy is calculated as the number of correct match/non-match responses divided by the total number of valid retrieval trials and multiplied by 100. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Higher accuracy indicates better performance.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Object-Scene Associative Memory Retrieval Reaction Time After Stimulation
Délai: Immediately before and after each 20-minute stimulation session during each crossover period

Reaction time is recorded by E-Prime 3.0 during the object-scene associative memory task. Mean reaction time is calculated using valid trials with correct responses. Trials with no response or reaction times shorter than 300 milliseconds are excluded. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Shorter reaction times indicate faster responses.

Immediately before and after each 20-minute stimulation session during each crossover period

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change From Pre-intervention in Word Recognition Accuracy After Stimulation
Délai: Immediately before and after each 20-minute stimulation session during each crossover period

Accuracy is assessed using a computerized word-recognition task programmed in E-Prime 3.0. Accuracy is calculated as the number of correct responses divided by the total number of analyzed trials and multiplied by 100. The two recognition cycles are analyzed separately. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Higher accuracy indicates better performance.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Word Recognition Reaction Time After Stimulation
Délai: Immediately before and after each 20-minute stimulation session during each crossover period

Reaction time is recorded by E-Prime 3.0 during the word-recognition task. Mean reaction time is calculated using valid trials with correct responses. The two recognition cycles are analyzed separately. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Shorter reaction times indicate faster responses.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Dual-Task Cost of 3-Meter Timed Up and Go Completion Time After Stimulation
Délai: Immediately before and after each 20-minute stimulation session during each crossover period

Participants perform the 3-meter Timed Up and Go test under single-task and dual-task conditions. During the dual-task condition, participants complete the test while continuously subtracting 3 from a randomly selected three-digit number. Total completion time is measured in seconds using the Mobility Lab wearable motion analysis system. Each condition is tested three times, and the mean completion time is used. Dual-task cost is calculated as: [(dual-task completion time - single-task completion time) / single-task completion time] × 100%. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. A higher dual-task cost indicates greater deterioration in mobility performance under cognitive load.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Dual-Task Cost of 7-Meter Walking Speed After Stimulation
Délai: Immediately before and after each 20-minute stimulation session during each crossover period

Participants complete the 7-meter walking test at their usual comfortable speed under single-task and dual-task conditions. During the dual-task condition, participants walk while continuously subtracting 3 from a randomly selected three-digit number. Walking speed is measured in meters per second using the Mobility Lab wearable motion analysis system. Each condition is tested three times, and the mean walking speed is used. Dual-task cost is calculated as: [(single-task walking speed - dual-task walking speed) / single-task walking speed] × 100%. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. A higher dual-task cost indicates a greater reduction in walking speed under cognitive load.

Immediately before and after each 20-minute stimulation session during each crossover period
Number of Participants With Any Stimulation-Associated Adverse Symptom
Délai: During and immediately after each 20-minute stimulation session in each crossover period

Safety is assessed using a standardized adverse-reaction questionnaire completed immediately after each stimulation session. Prespecified symptoms include tingling, itching, burning sensation, pain, skin redness, fatigue, visual sensations, difficulty concentrating, and mood changes. Each symptom is rated as none, mild, moderate, or severe, corresponding to scores of 0, 1, 2, and 3, respectively. Other spontaneously reported symptoms are also recorded. For each stimulation condition, a participant is counted as having an adverse symptom if at least one prespecified or spontaneously reported symptom is present with a severity score of 1 or higher during or immediately after stimulation.

During and immediately after each 20-minute stimulation session in each crossover period

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

30 juillet 2026

Achèvement primaire (Estimé)

15 juillet 2027

Achèvement de l'étude (Estimé)

30 juillet 2027

Dates d'inscription aux études

Première soumission

8 août 2026

Première soumission répondant aux critères de contrôle qualité

13 août 2026

Première publication (Réel)

18 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

12 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

8 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • ID: 102772026RT090

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner